Clinical Trial Update: Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI [Phase 4]

View source ↗

Summary

Phase 4 trial investigating oral vancomycin vs placebo to prevent Clostridioides difficile infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Creighton University | Conditions: CDI | Phase 4 | Status: WITHDRAWN